Cargando…
An ETP model (exclusion-tolerance-progression) for multi drug resistance
BACKGROUND: It is known that sensitivity or resistance of tumor cells to a given chemotherapeutic agent is an acquired characteristic(s), depending on the heterogeneity of the tumor mass subjected to the treatment. The clinical success of a chemotherapeutic regimen depends on the ratio of sensitive...
Autor principal: | Kannan, Subburaj |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1131929/ https://www.ncbi.nlm.nih.gov/pubmed/15857507 http://dx.doi.org/10.1186/1742-4682-2-17 |
Ejemplares similares
-
Origins of ETP leukemia
por: Booth, Christopher A. G., et al.
Publicado: (2018) -
On the Origin of ETP Leukemias
por: Tesio, Melania
Publicado: (2018) -
Mutational landscape of adult ETP-ALL
por: Neumann, Martin, et al.
Publicado: (2013) -
Etp1 confers arsenite resistance by affecting ACR3 expression
por: Romero, Antonia M, et al.
Publicado: (2022) -
Comparison of characteristics and outcomes on ETP-ALL/LBL and non-ETP ALL patients receiving allogeneic hematopoietic stem cell transplantation
por: Chen, Juan, et al.
Publicado: (2023)